Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Perspective Therapeutics, Inc. Common Stock (NY:CATX)

2.640 -0.090 (-3.30%)
Official Closing Price Updated: 8:00 PM EDT, Oct 30, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,030,439
Open 2.710
Bid (Size) 2.650 (11)
Ask (Size) 2.700 (1)
Prev. Close 2.730
Today's Range 2.600 - 2.750
52wk Range 1.600 - 12.90
Shares Outstanding 280,571,026
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
These stocks are moving in today's session
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga

Performance

YTD
-20.2%
-20.2%
1 Month
-23.0%
-23.0%
3 Month
-31.2%
-31.2%
6 Month
+6.9%
+6.9%
1 Year
-77.0%
-77.0%

More News

Read More
Top movers analysis in the middle of the day on 2025-10-20: top gainers and losers in today's session.
Via Chartmill
Earnings Scheduled For May 12, 2025
Via Benzinga
Gapping stocks in Monday's session
Via Chartmill
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session.
Via Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Which stocks are experiencing notable movement on Friday?
Via Chartmill
This Aptiv Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
PERSPECTIVE THERAPEUTICS INC (NYSEARCA:CATX) Surpasses Q2 2025 Revenue Estimates with Narrower Loss
Via Chartmill
Perspective Therapeutics Reports Q2 Loss
Via The Motley Fool
Topics Economy
Earnings Scheduled For August 13, 2025
Via Benzinga
A Look Ahead: Perspective Therapeutics's Earnings Forecast
Via Benzinga
Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices
Via FinancialNewsMedia
Cancer Rates Are Surging in Young Adults — Here’s Where the Smart Money Is Going
Via FinancialNewsMedia
What's going on in today's session
Via Chartmill
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Which stocks are moving on Tuesday?
Via Chartmill
Top movers in Friday's pre-market session
Via Chartmill
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 26, 2025
Via Benzinga
Perspective Therapeutics' Cancer-Focused Radiotherapy Portfolio Has Upside Potentional, Says Analyst
Via Benzinga
Perspective Therapeutics Touts Encouraging Updated Data From Gastrointestinal Cancer Trial, Stock Soars
Via Benzinga
Here's How Donald Trump Could Shake Up Health Care — And Biotech Stocks
Via Investor's Business Daily
Topics Government
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga

Frequently Asked Questions

Is Perspective Therapeutics, Inc. Common Stock publicly traded?
Yes, Perspective Therapeutics, Inc. Common Stock is publicly traded.
What exchange does Perspective Therapeutics, Inc. Common Stock trade on?
Perspective Therapeutics, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Perspective Therapeutics, Inc. Common Stock?
The ticker symbol for Perspective Therapeutics, Inc. Common Stock is CATX on the New York Stock Exchange
What is the current price of Perspective Therapeutics, Inc. Common Stock?
The current price of Perspective Therapeutics, Inc. Common Stock is 2.640
When was Perspective Therapeutics, Inc. Common Stock last traded?
The last trade of Perspective Therapeutics, Inc. Common Stock was at 10/30/25 08:00 PM ET
What is the market capitalization of Perspective Therapeutics, Inc. Common Stock?
The market capitalization of Perspective Therapeutics, Inc. Common Stock is 740.71M
How many shares of Perspective Therapeutics, Inc. Common Stock are outstanding?
Perspective Therapeutics, Inc. Common Stock has 741M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.